Abiopharma

RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement

RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock

New SEC Filing for Avanos Medical Inc. (NYSE:AVNS)

Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

Merck Announces First-Quarter 2026 Dividend

European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

Lilly to participate in Citis 2025 Global Healthcare Conference

Henlius與Organon宣布POHERDY® (pertuzumab-dpzb)獲美國FDA核准，成為美國首款PERJETA (pertuzumab)生物相似藥

Henlius与Organon宣布POHERDY® (pertuzumab-dpzb)获美国FDA批准，成为美国首款PERJETA (pertuzumab)生物类似药